Critical Illness Clinical Trial
Official title:
Functional Recovery in Critically Ill Children - the Wee-Cover Pilot Study
Verified date | November 2013 |
Source | McMaster University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Observational |
Intensive Care Unit-acquired weakness (ICU-AW) is a well-recognized, important and
preventable sequelae of critical illness, affecting up to 60% of adult ICU patient. ICU-AW
is associated with increased mortality and length of stay, and negatively impacts long-term
functional outcomes and quality of life in affected patients and their caregivers. While
delayed mobilization adversely affects clinical outcomes, early rehabilitation in the
critically ill adult population is safe, feasible, cost effective, results in more
ventilator free-days and better functional outcomes at hospital discharge. In contrast,
there is a paucity of this research in pediatrics. Our research suggests that immobilization
is common in critically ill children, and rehabilitation is delayed particularly in the
sickest children who are arguably at highest risk of morbidity. It is unclear however,
whether delayed rehabilitation leads to adverse outcomes in critically ill children, as has
been demonstrated in adults. Our objectives of this study are to evaluate if immobilization
and delayed rehabilitation negatively impacts short-term clinical outcomes and the time to
functional recovery in critically ill children. The investigators hypothesize that the
following factors may influence functional recovery and morbidity in critically ill
children:
- Pre-morbid condition
- Age
- Time-to-initiation of acute rehabilitation
- Critical illness disease severity
Status | Completed |
Enrollment | 30 |
Est. completion date | November 2013 |
Est. primary completion date | November 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 12 Months to 17 Years |
Eligibility |
Inclusion Criteria: - Age over 12 months to 17 years - PCCU stay of = 48 hours - Patient is limited to bed-rest and has not been mobilized during the first 48 hours of PCCU admission - Equal to or greater than one organ dysfunction on PCCU admission (as measured by PELOD) - Informed consent of patient/substitute decision maker. Exclusion Criteria: - Age: < 12 months or =18 years - Patients admitted to step-down/intermediate care - Patients transferred from Neonatal intensive care unit and never discharge home. iv) Patients who are already mobilizing well, or are at baseline functional status at time of screening v) Admission diagnosis of a neuromuscular disorder: e.g. Acute Guillain-Barré Syndrome, Botulism, Myasthenia Gravis), or acute spinal cord injury/transverse myelitis vi) Not expected to survive PCCU/hospital stay vii) Previously enrolled into study less than 6 months ago and/or still undergoing study procedures at time of screening |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Canada | McMaster Children's Hospital | Hamilton | Ontario |
Lead Sponsor | Collaborator |
---|---|
Karen Choong |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Feasibility and reliability of screening for PCCU-acquired weakness | The most appropriate method of screening and diagnosing PCCU-acquired weakness has not been well established given the many challenges in ascertainment in this population. Hence, one of the objectives of this study is to determine whether manual muscle strength testing is a feasible and reliable method of screening for this important disorder in the critically ill pediatric population. Muscle strength will be quantified clinically using the (MRC) score by 2 independent assessors. For a subset of age appropriate (= 4 years), we will determine their hand-grip strength using a hand dynamometer or Martin Vigorimeter, depending on their age. | Duration of Hospitalization, 3 and 6 months follow-up | No |
Primary | Feasibility | Feasibility will be determined by the consent and enrolment rate, and the protocol adherence and follow-up rates. | 12 months | No |
Secondary | Functional Recovery | Functional Recovery will be measured by the following standardized, validate pediatric assessment tools of function, as defined by the International Classification of Functioning, Disability and Health (ICF): 1) Pediatric Evaluation of Disability Inventory (PEDI); 2) Participation and Environment Measure - children and youth version (PEM-CY), and preschool version; 3) Pediatric Overall Performance Category score (POPC); 4) Pediatric Cerebral Performance Category Score (PCPC) | Baseline, 3 and 6 month follow-up | No |
Secondary | Pediatric Critical care Unit (PCCU) clinical outcomes | PCCU outcomes will be assessed by the following: Ventilator-free days, PCCU mortality, length of PCCU and hospital stay, and the incidence of PCCU-acquired weakness | at 30 days and duration of hospitalization | No |
Secondary | Muscle Strength | In an age-appropriate subgroup, the following measurements will be conducted: Muscle Strength and aerobic fitness testing (age = 5 years, and/or able to cognitively and physically comply with strength and fitness tests) Measurement of muscle strength using BIODEX and hand grip strength, and assessment of lean mass (Bioelectrical impedance analysis) |
Hospital discharge and at 3 and 6 month follow-up | No |
Secondary | Parental or caregiver stress | Parental or caregiver stress will be measured with the Parental Stress Index (PSI) | 3 month follow-up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT06037928 -
Plasma Sodium and Sodium Administration in the ICU
|
||
Completed |
NCT03671447 -
Enhanced Recovery After Intensive Care (ERIC)
|
N/A | |
Recruiting |
NCT03941002 -
Continuous Evaluation of Diaphragm Function
|
N/A | |
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Completed |
NCT04239209 -
Effect of Intensivist Communication on Surrogate Prognosis Interpretation
|
N/A | |
Completed |
NCT05531305 -
Longitudinal Changes in Muscle Mass After Intensive Care
|
N/A | |
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Completed |
NCT02916004 -
The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients.
|
N/A | |
Recruiting |
NCT05883137 -
High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
|
||
Completed |
NCT04479254 -
The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study)
|
N/A | |
Recruiting |
NCT04475666 -
Replacing Protein Via Enteral Nutrition in Critically Ill Patients
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
Withdrawn |
NCT04043091 -
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
|
N/A | |
Recruiting |
NCT02989051 -
Fluid Restriction Keeps Children Dry
|
Phase 2/Phase 3 | |
Recruiting |
NCT02922998 -
CD64 and Antibiotics in Human Sepsis
|
N/A | |
Completed |
NCT03048487 -
Protein Consumption in Critically Ill Patients
|
||
Completed |
NCT02899208 -
Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients?
|
N/A | |
Recruiting |
NCT02163109 -
Oxygen Consumption in Critical Illness
|